Gap-f launches strategy plan!


On March 1, 2022, the GAP-f network held a virtual event to launch its ambitious three-year strategy, spanning from 2022-2024. Through this event, the network solidified the WHO’s commitment to advancing health outcomes for children globally.

GAP-f’s three-year strategy (2022–2024) builds from the work undertaken to date by the network of leading partners, both individually and collectively, through GAP-f. The initial Phase I strategy focused on HIV, tuberculosis (TB) and hepatitis C products,

Read More

Launch of Global Accelerator for Paediatric Formulations (GAP-f) by WHO


Penta is the lead of the Clinical Research Working Group for the newly launched Global Accelerator for Paediatric Formulations (GAP-f), a network led by the World Health Organisation.

Read More